CTAK by CorneaGen: A New Era in Keratoconus Care
For years, keratoconus treatment has been unpredictable—and CorneaGen’s Corneal Tissue Addition Keratoplasty (CTAK) may change that. In this video, Dr….
FDA Accepts NDA for Glaukos’ Corneal Cross-Linking Drug Treatment
Glaukos’ Epioxa eyes FDA approval as the first non-invasive cross-linking therapy for keratoconus. Glaukos Corporation (California, USA) announced yesterday that…
latest posts
